Emerald Development Managers logo

Emerald Development Managers

North America, New York, United States, New York

Description

Emerald Development Managers is a venture capital firm focusing on early-stage growth equity investments.

Investor Profile

Emerald Development Managers has made 37 investments, with 2 in the past 12 months and 16% as lead.

Stage Focus

  • Series A (35%)
  • Series Unknown (19%)
  • Series B (16%)
  • Seed (16%)
  • Series C (11%)
  • Series D (3%)

Country Focus

  • United States (97%)
  • United Kingdom (3%)

Industry Focus

  • Biotechnology
  • Medical
  • Cyber Security
  • Health Care
  • Information Technology
  • Artificial Intelligence (Ai)
  • Cloud Security
  • Software
  • Security
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emerald Development Managers frequently co-invest with?

Razor's Edge Ventures
North America, Virginia, United States, Reston
Co-Investments: 4
Evolution Equity Partners
North America, New York, United States, New York
Co-Investments: 3
Alpha Intelligence Capital
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 3
CIG Spectrum Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 9
Robin Hood Ventures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 4
GR
North America, New York, United States, Harrison
Co-Investments: 5
Prelude Fund
North America, Utah, United States, Salt Lake City
Co-Investments: 3
Ten Eleven Ventures
North America, California, United States, Burlingame
Co-Investments: 3
RRE Ventures
North America, New York, United States, New York
Co-Investments: 3
SoGal Ventures
North America, New York, United States, New York
Co-Investments: 3

Which angels does Emerald Development Managers often collaborate with?

AP
North America, New York, United States, New York
Shared Deals: 1
CT
Europe, Zurich, Switzerland
Shared Deals: 1
Shared Deals: 1
MF
North America, California, United States, Mountain View
Shared Deals: 1
AW
Europe, Zurich, Switzerland
Shared Deals: 1
ZL
North America, Texas, United States, Austin
Shared Deals: 1
JV
North America, New Jersey, United States, Deal
Shared Deals: 1
Dan Amiga
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 1

What are some of recent deals done by Emerald Development Managers?

Proscia

Philadelphia, Pennsylvania, United States

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series DMar 19, 2025
Amount Raised: $50,000,000
Uviquity

Raleigh, North Carolina, United States

Uviquity is a firm that wants to encourage safety for their clients.

Artificial Intelligence (AI)Cyber SecuritySaaS
Series UnknownSep 5, 2024
Amount Raised: $6,674,620
Proscia

Philadelphia, Pennsylvania, United States

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series CJan 11, 2024
Amount Raised: $9,000,000
ETCH

Chevy Chase, Maryland, United States

ETCH commercializes a chemical process that generates low-cost hydrogen by splitting natural gas into hydrogen and solid carbon.

ChemicalGreenTechIndustrial
SeedJul 25, 2023
Amount Raised: $7,500,000
Cyware

Jersey City, New Jersey, United States

Cyware provides cyber fusion solutions to help businesses detect and stop cyberattacks.

Cloud SecurityCyber SecurityInformation TechnologySecurity
Series CJun 29, 2023
Amount Raised: $30,000,000
Transcend Therapeutics

Waltham, Massachusetts, United States

Transcend Therapeutics offers novel pharmaceuticals for the critical care market.

BiotechnologyHealth CarePharmaceutical
Series AFeb 23, 2023
Amount Raised: $40,000,000
Torigen Pharmaceuticals

Farmington, Connecticut, United States

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

BiotechnologyHealth CareOncologyVeterinary
Series ANov 16, 2022
Amount Raised: $13,000,000
Evolved By Nature

Medford, Massachusetts, United States

Evolved By Nature is a biotech company that focuses on creating Activated Silk technology.

BiotechnologyChemicalProduct ResearchSustainability
Series CJun 28, 2022
Amount Raised: $120,000,000
CybSafe

London, England, United Kingdom

CybSafe is a data analytics and behavioral security platform that assists people in making better security decisions.

AnalyticsCyber SecurityNetwork SecuritySoftware
Series BJun 6, 2022
Amount Raised: $28,000,000
Proscia

Philadelphia, Pennsylvania, United States

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series CJun 3, 2022
Amount Raised: $36,617,270